183 related articles for article (PubMed ID: 34340981)
1. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli
Chung SH; Wener M; Bays AM; Rahbar H; Morishima C; Bryan AB; Fink SL; Cohen S; Mani NS; Chaudhary A; Gardner GC
Ann Rheum Dis; 2021 Oct; 80(10):e165. PubMed ID: 34340981
[No Abstract] [Full Text] [Related]
2. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli
Benucci M; Damiani A; Infantino M; Manfredi M; Grossi V; Lari B; Li Gobbi F; Sarzi Puttini P
Ann Rheum Dis; 2021 Oct; 80(10):e166. PubMed ID: 34340979
[No Abstract] [Full Text] [Related]
3. Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli
Bonelli M; Aletaha D
Ann Rheum Dis; 2021 Oct; 80(10):e167. PubMed ID: 34340982
[No Abstract] [Full Text] [Related]
4. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli
Connolly CM; Koenig D; Ravi SN; Azar A; Kant S; Dalal M; Duchen J; Seo P; Antiochos B; Paik JJ; Geetha D
Ann Rheum Dis; 2021 Oct; 80(10):e164. PubMed ID: 34340978
[No Abstract] [Full Text] [Related]
5. Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff
Bonelli M; Aletaha D
Ann Rheum Dis; 2021 Oct; 80(10):e163. PubMed ID: 34272251
[No Abstract] [Full Text] [Related]
6. Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'.
Westhoff TH; Seibert FS; Anft M; Blazquez-Navarro A; Skrzypczyk S; Doevelaar A; Hölzer B; Paniskaki K; Dolff S; Wilde B; Witzke O; Braun J; Stervbo U; Babel N
Ann Rheum Dis; 2021 Oct; 80(10):e162. PubMed ID: 34272253
[No Abstract] [Full Text] [Related]
7. SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response.
Bonelli MM; Mrak D; Perkmann T; Haslacher H; Aletaha D
Ann Rheum Dis; 2021 Oct; 80(10):1355-1356. PubMed ID: 33958323
[No Abstract] [Full Text] [Related]
8. Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab.
Bacova B; Kohutova Z; Zubata I; Gaherova L; Kucera P; Heizer T; Mikesova M; Karel T; Novak J
Clin Exp Med; 2023 Jun; 23(2):371-379. PubMed ID: 35352210
[TBL] [Abstract][Full Text] [Related]
9. Impaired Humoral Immunogenicity of SARS-CoV-2 Vaccination in Patients With Rheumatoid Arthritis.
Moine CL; Soyfoo MS; Mekkaoui L; Dahma H; Tant L
J Rheumatol; 2022 Jul; 49(7):855-858. PubMed ID: 35105706
[No Abstract] [Full Text] [Related]
10. Response to: 'Correspondence on 'EULAR December 2020 View points on SARS-CoV-2 vaccination in patients with RMDs'' by Bugatti
Bijlsma JWJ;
Ann Rheum Dis; 2021 Oct; 80(10):e157. PubMed ID: 33906856
[No Abstract] [Full Text] [Related]
11. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.
Ehmsen S; Asmussen A; Jeppesen SS; Nilsson AC; Østerlev S; Vestergaard H; Justesen US; Johansen IS; Frederiksen H; Ditzel HJ
Cancer Cell; 2021 Aug; 39(8):1034-1036. PubMed ID: 34348121
[No Abstract] [Full Text] [Related]
12. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
Zollner A; Watschinger C; Rössler A; Farcet MR; Penner A; Böhm V; Kiechl SJ; Stampfel G; Hintenberger R; Tilg H; Koch R; Antlanger M; Kreil TR; Kimpel J; Moschen AR
EBioMedicine; 2021 Aug; 70():103539. PubMed ID: 34391087
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
14. Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapy.
Teh BW; Tam CS
Leuk Lymphoma; 2021 Dec; 62(12):2820-2822. PubMed ID: 34313175
[No Abstract] [Full Text] [Related]
15. COVID-19 vaccination and antirheumatic therapy.
Arnold J; Winthrop K; Emery P
Rheumatology (Oxford); 2021 Aug; 60(8):3496-3502. PubMed ID: 33710296
[TBL] [Abstract][Full Text] [Related]
16. Severe COVID pneumonia and undetectable B cells after vaccination in patients previously treated with rituximab: a case series.
Sakano T; Bittner EA; Chang MG
Postgrad Med; 2022 Mar; 134(2):239-243. PubMed ID: 35129061
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses.
Hollstein MM; Münsterkötter L; Schön MP; Bergmann A; Husar TM; Abratis A; Eidizadeh A; Dierks S; Schaffrinski M; Zachmann K; Schmitz A; Holsapple JS; Stanisz-Bogeski H; Schanz J; Fischer A; Groß U; Leha A; Zautner AE; Schnelle M; Erpenbeck L
Allergy; 2022 Aug; 77(8):2560-2564. PubMed ID: 35567394
[No Abstract] [Full Text] [Related]
18. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers.
Messmer M; Wagner-Johnston N
Leuk Lymphoma; 2021 Dec; 62(12):3019-3022. PubMed ID: 34151698
[No Abstract] [Full Text] [Related]
20. Answer to Mungmunpuntipantip et al. "SARS CoV-2 vaccine AND rituximab" Joint Bone Spine 2021;88:105281.
Verhoeven F; Lepiller Q; Hecquet S; Prati C; Wendling D
Joint Bone Spine; 2022 Jan; 89(1):105283. PubMed ID: 34601112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
